Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers.

× No keyword cloud information.

97 in total

1. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.

Authors: Guang-Xia Chen; Li-Hong Zheng; Shi-Yu Liu; Xiao-Hua He
Journal: World J Gastroenterol Date: 2011-10-14 Impact factor: 5.742

2. Enhanced adenovirus transduction of hMSCs using 3D hydrogel cell carriers.

Authors: Alexander J Neumann; Josh Schroeder; Mauro Alini; Charles W Archer; Martin J Stoddart
Journal: Mol Biotechnol Date: 2013-02 Impact factor: 2.695

Review 3. Progress and challenges in viral vector manufacturing.

Authors: Johannes C M van der Loo; J Fraser Wright
Journal: Hum Mol Genet Date: 2015-10-30 Impact factor: 6.150

4. Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

Authors: Chinthalapally V Rao; Jagan Mohan R Patlolla; Li Qian; Yuting Zhang; Misty Brewer; Altaf Mohammed; Dhimant Desai; Shantu Amin; Stan Lightfoot; Levy Kopelovich
Journal: Neoplasia Date: 2013-09 Impact factor: 5.715

Review 5. Specific targeting of gene therapy to prostate cancer using a two-step transcriptional amplification system.

Authors: Marxa L Figueiredo; Makoto Sato; Mai Johnson; Lily Wu
Journal: Future Oncol Date: 2006-06 Impact factor: 3.404

Review 6. Gene therapy in head and neck cancer: a review.

Authors: E Chisholm; U Bapat; C Chisholm; G Alusi; G Vassaux
Journal: Postgrad Med J Date: 2007-12 Impact factor: 2.401

Review 7. Exploiting endocytosis for nanomedicines.

Authors: Akin Akinc; Giuseppe Battaglia
Journal: Cold Spring Harb Perspect Biol Date: 2013-11-01 Impact factor: 10.005

Review 8. The first 30 years of p53: growing ever more complex.

Authors: Arnold J Levine; Moshe Oren
Journal: Nat Rev Cancer Date: 2009-10 Impact factor: 60.716

9. Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model.

Authors: Debanjan Dhar; Jacqueline F Spencer; Karoly Toth; William S M Wold
Journal: Mol Ther Date: 2009-07-14 Impact factor: 11.454

10. The natural product avrainvillamide binds to the oncoprotein nucleophosmin.

Authors: Jeremy E Wulff; Romain Siegrist; Andrew G Myers
Journal: J Am Chem Soc Date: 2007-10-25 Impact factor: 15.419